Melanie L Praught1, Michael G Shlipak. 1. General Internal Medicine Section, Veterans Affairs Medical Center, San Francisco, California 94121, USA.
Abstract
PURPOSE OF REVIEW: Serum creatinine levels are strongly associated with longitudinal risk for cardiovascular disease and mortality. Recent studies addressed whether worsening renal function - defined by small increases in creatinine - is independently associated with adverse outcomes. This review evaluates the recent literature on worsened renal function as an independent risk factor. RECENT FINDINGS: Studies have evaluated worsening renal function as a predictor of cardiovascular outcomes and mortality in three settings: cardiac surgery patients, hospitalized heart failure patients, and ambulatory coronary artery disease patients. Small creatinine changes following cardiac surgery were strongly associated with mortality risk. One study found a J-shaped association between 48 h post surgery creatinine change and 30-day mortality risk. Compared with patients with creatinine decreases of 0-0.3 mg/dl, patients with creatinine increases less than 0.5 mg/dl had a twofold adjusted mortality risk and those with creatinine increases of at least 0.5 mg/dl had a nearly sixfold mortality risk; surprisingly those with decreases over 0.3 mg/dl had a twofold adjusted risk. Worsening renal function was also a strong predictor of mortality for hospitalized heart failure patients independent of baseline creatinine; the magnitude of creatinine rise appeared to be linearly associated with mortality risk. However, one study found no independent association between worsening renal function and cardiovascular or mortality risk over longer follow-up. SUMMARY: Acute elevations in serum creatinine had a linear association with increased risk for adverse outcomes among patients hospitalized for cardiac surgery or heart failure. Future studies should determine interventions to prevent and treat in-hospital worsening renal function to reduce the risk for adverse outcomes.
PURPOSE OF REVIEW: Serum creatinine levels are strongly associated with longitudinal risk for cardiovascular disease and mortality. Recent studies addressed whether worsening renal function - defined by small increases in creatinine - is independently associated with adverse outcomes. This review evaluates the recent literature on worsened renal function as an independent risk factor. RECENT FINDINGS: Studies have evaluated worsening renal function as a predictor of cardiovascular outcomes and mortality in three settings: cardiac surgery patients, hospitalized heart failurepatients, and ambulatory coronary artery diseasepatients. Small creatinine changes following cardiac surgery were strongly associated with mortality risk. One study found a J-shaped association between 48 h post surgery creatinine change and 30-day mortality risk. Compared with patients with creatinine decreases of 0-0.3 mg/dl, patients with creatinine increases less than 0.5 mg/dl had a twofold adjusted mortality risk and those with creatinine increases of at least 0.5 mg/dl had a nearly sixfold mortality risk; surprisingly those with decreases over 0.3 mg/dl had a twofold adjusted risk. Worsening renal function was also a strong predictor of mortality for hospitalized heart failurepatients independent of baseline creatinine; the magnitude of creatinine rise appeared to be linearly associated with mortality risk. However, one study found no independent association between worsening renal function and cardiovascular or mortality risk over longer follow-up. SUMMARY: Acute elevations in serum creatinine had a linear association with increased risk for adverse outcomes among patients hospitalized for cardiac surgery or heart failure. Future studies should determine interventions to prevent and treat in-hospital worsening renal function to reduce the risk for adverse outcomes.
Authors: Matthew P Welberry Smith; Rosamonde E Banks; Steven L Wood; Andrew J P Lewington; Peter J Selby Journal: Nat Rev Nephrol Date: 2009-10-27 Impact factor: 28.314
Authors: Cristian Pattaro; Alessandro De Grandi; Veronique Vitart; Caroline Hayward; Andre Franke; Yurii S Aulchenko; Asa Johansson; Sarah H Wild; Scott A Melville; Aaron Isaacs; Ozren Polasek; David Ellinghaus; Ivana Kolcic; Ute Nöthlings; Lina Zgaga; Tatijana Zemunik; Carsten Gnewuch; Stefan Schreiber; Susan Campbell; Nick Hastie; Mladen Boban; Thomas Meitinger; Ben A Oostra; Peter Riegler; Cosetta Minelli; Alan F Wright; Harry Campbell; Cornelia M van Duijn; Ulf Gyllensten; James F Wilson; Michael Krawczak; Igor Rudan; Peter P Pramstaller Journal: BMC Med Genet Date: 2010-03-11 Impact factor: 2.103
Authors: Arvind Bagga; Aysin Bakkaloglu; Prasad Devarajan; Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Michael Joannidis; Adeera Levin Journal: Pediatr Nephrol Date: 2007-07-31 Impact factor: 3.714
Authors: Neil J Glassford; Antoine G Schneider; Shengyuan Xu; Glenn M Eastwood; Helen Young; Leah Peck; Per Venge; Rinaldo Bellomo Journal: Intensive Care Med Date: 2013-08-06 Impact factor: 17.440
Authors: Derek S Wheeler; Prasad Devarajan; Qing Ma; Kelli Harmon; Marie Monaco; Natalie Cvijanovich; Hector R Wong Journal: Crit Care Med Date: 2008-04 Impact factor: 7.598